broad_sample	InChIKey	pert_iname	pubchem_cid	moa	pert_type	control_type	smiles	InChI
BRD-K80935598-001-01-1	ZYVXTMKTGDARKR-UHFFFAOYSA-N	AZ191	72716071	DYRK inhibitor	trt	NA	COc1cc(N2CCN(C)CC2)ccc1N=c1nc(-c2cn(C)c3cnccc23)cc[nH]1	InChI=1S/C24H27N7O/c1-29-10-12-31(13-11-29)17-4-5-21(23(14-17)32-3)28-24-26-9-7-20(27-24)19-16-30(2)22-15-25-8-6-18(19)22/h4-9,14-16H,10-13H2,1-3H3,(H,26,27,28)
BRD-K85776940-001-01-9	ODADKLYLWWCHNB-UHFFFAOYSA-N	delta-Tocotrienol	5282350	HMGCR inhibitor	trt	NA	CC(C)=CCCC(C)=CCCC(C)=CCCC1(C)CCc2cc(O)cc(C)c2O1	InChI=1S/C27H40O2/c1-20(2)10-7-11-21(3)12-8-13-22(4)14-9-16-27(6)17-15-24-19-25(28)18-23(5)26(24)29-27/h10,12,14,18-19,28H,7-9,11,13,15-17H2,1-6H3
BRD-K25611237-001-02-1	QDBVSOZTVKXUES-UHFFFAOYSA-N	ML324	44143209	histone lysine demethylase inhibitor	trt	NA	CN(C)CCCNC(=O)c1ccc(-c2cc(O)c3ncccc3c2)cc1	InChI=1S/C21H23N3O2/c1-24(2)12-4-11-23-21(26)16-8-6-15(7-9-16)18-13-17-5-3-10-22-20(17)19(25)14-18/h3,5-10,13-14,25H,4,11-12H2,1-2H3,(H,23,26)
BRD-K66430217-001-03-8	DXZRBHUCOHBAHP-UHFFFAOYSA-N	KH-CB19	44237094	CDC inhibitor	trt	NA	CCOC(=O)c1c(C(C#N)C=N)c2ccc(Cl)c(Cl)c2n1C	InChI=1S/C15H13Cl2N3O2/c1-3-22-15(21)14-11(8(6-18)7-19)9-4-5-10(16)12(17)13(9)20(14)2/h4-6,8,18H,3H2,1-2H3
BRD-K38627885-001-01-9	DWFWRWOABQRHJO-UHFFFAOYSA-N	APY0201	56927660	phosphoinositide dependent kinase inhibitor	trt	NA	Cc1cccc(C=NN=c2cc(N3CCOCC3)n3[nH]c(-c4ccncc4)cc3n2)c1	InChI=1S/C23H23N7O/c1-17-3-2-4-18(13-17)16-25-27-21-15-23(29-9-11-31-12-10-29)30-22(26-21)14-20(28-30)19-5-7-24-8-6-19/h2-8,13-16,28H,9-12H2,1H3
BRD-K67578145-001-09-7	DEZZLWQELQORIU-UHFFFAOYSA-N	GDC-0879	11717001	RAF inhibitor	trt	NA	OCCn1cc(-c2ccc3c(c2)CCC3=NO)c(-c2ccncc2)n1	InChI=1S/C19H18N4O2/c24-10-9-23-12-17(19(21-23)13-5-7-20-8-6-13)15-1-3-16-14(11-15)2-4-18(16)22-25/h1,3,5-8,11-12,24-25H,2,4,9-10H2
BRD-K16803204-001-01-6	RIJLVEAXPNLDTC-UHFFFAOYSA-N	filgotinib	49831257	JAK inhibitor	trt	NA	O=C(N=c1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2[nH]1)C1CC1	InChI=1S/C21H23N5O3S/c27-20(17-8-9-17)23-21-22-19-3-1-2-18(26(19)24-21)16-6-4-15(5-7-16)14-25-10-12-30(28,29)13-11-25/h1-7,17H,8-14H2,(H,23,24,27)
BRD-K00818915-003-01-8	YGUFCDOEKKVKJK-UHFFFAOYSA-N	SHP099	118238298	protein tyrosine kinase inhibitor	trt	NA	CC1(N)CCN(c2cnc(-c3cccc(Cl)c3Cl)c(=N)[nH]2)CC1	InChI=1S/C16H19Cl2N5/c1-16(20)5-7-23(8-6-16)12-9-21-14(15(19)22-12)10-3-2-4-11(17)13(10)18/h2-4,9H,5-8,20H2,1H3,(H2,19,22)
BRD-K19477839-001-07-6	BCZUAADEACICHN-UHFFFAOYSA-N	SGX523	24779724	hepatocyte growth factor receptor inhibitor	trt	NA	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1	InChI=1S/C18H13N7S/c1-24-11-13(10-20-24)16-6-7-17-21-22-18(25(17)23-16)26-14-4-5-15-12(9-14)3-2-8-19-15/h2-11H,1H3
BRD-K97452254-001-01-3	AOJQBABIGYNZOY-UHFFFAOYSA-N	AMG-925	NA	CDK inhibitor	trt	NA	CC1CCC(n2c3c[nH]ccc3c3cnc(=Nc4ccc5c(n4)CCN(C(=O)CO)C5)nc32)CC1	InChI=1S/C26H29N7O2/c1-16-2-5-18(6-3-16)33-22-13-27-10-8-19(22)20-12-28-26(31-25(20)33)30-23-7-4-17-14-32(24(35)15-34)11-9-21(17)29-23/h4,7-8,10,12-13,16,18,27,34H,2-3,5-6,9,11,14-15H2,1H3
BRD-K63631219-001-01-6	XIXXNJFWPAVKFR-UHFFFAOYSA-N	quazinone	57046956	phosphodiesterase inhibitor	trt	NA	Cc1c(O)nc2n1Cc1c(Cl)cccc1N2	InChI=1S/C11H10ClN3O/c1-6-10(16)14-11-13-9-4-2-3-8(12)7(9)5-15(6)11/h2-4,16H,5H2,1H3,(H,13,14)
BRD-K98203492-003-04-1	WBKCKEHGXNWYMO-UHFFFAOYSA-N	GSK-J4	71729975	histone lysine demethylase inhibitor	trt	NA	CCOC(=O)CCN=c1cc(N2CCc3ccccc3CC2)[nH]c(-c2ccccn2)n1	InChI=1S/C24H27N5O2/c1-2-31-23(30)10-14-26-21-17-22(28-24(27-21)20-9-5-6-13-25-20)29-15-11-18-7-3-4-8-19(18)12-16-29/h3-9,13,17H,2,10-12,14-16H2,1H3,(H,26,27,28)
BRD-K12737986-001-01-4	JNAHVYVRKWKWKQ-UHFFFAOYSA-N	veliparib	11842604	PARP inhibitor	trt	NA	CC1(c2nc3c(C(N)=O)cccc3[nH]2)CCCN1	InChI=1S/C13H16N4O/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17)
BRD-K64881305-001-05-2	QJZRFPJCWMNVAV-UHFFFAOYSA-N	ispinesib	6851740	kinesin inhibitor	trt	NA	Cc1ccc(C(=O)N(CCCN)C(c2nc3cc(Cl)ccc3c(=O)n2Cc2ccccc2)C(C)C)cc1	InChI=1S/C30H33ClN4O2/c1-20(2)27(34(17-7-16-32)29(36)23-12-10-21(3)11-13-23)28-33-26-18-24(31)14-15-25(26)30(37)35(28)19-22-8-5-4-6-9-22/h4-6,8-15,18,20,27H,7,16-17,19,32H2,1-3H3
BRD-K99433989-001-02-9	VFSUUTYAEQOIMW-UHFFFAOYSA-N	SAG	NA	smoothened receptor agonist	trt	NA	CNC1CCC(N(Cc2cccc(-c3ccncc3)c2)C(=O)c2sc3ccccc3c2Cl)CC1	InChI=1S/C28H28ClN3OS/c1-30-22-9-11-23(12-10-22)32(28(33)27-26(29)24-7-2-3-8-25(24)34-27)18-19-5-4-6-21(17-19)20-13-15-31-16-14-20/h2-8,13-17,22-23,30H,9-12,18H2,1H3
BRD-K93942811-001-01-3	VUIRVWPJNKZOSS-UHFFFAOYSA-N	ML-323	60167849	ubiquitin specific protease inhibitor	trt	NA	Cc1c[nH]c(-c2ccccc2C(C)C)nc1=NCc1ccc(-n2ccnn2)cc1	InChI=1S/C23H24N6/c1-16(2)20-6-4-5-7-21(20)23-24-14-17(3)22(27-23)25-15-18-8-10-19(11-9-18)29-13-12-26-28-29/h4-14,16H,15H2,1-3H3,(H,24,25,27)
BRD-K70446295-001-01-7	RTONCGPIJCWPSI-UHFFFAOYSA-N	EPZ015666	90241673	protein arginine N-methyltransferase inhibitor	trt	NA	O=C(CNC(O)c1cc(=NC2COC2)[nH]cn1)CN1CCc2ccccc2C1	InChI=1S/C20H25N5O3/c26-17(10-25-6-5-14-3-1-2-4-15(14)9-25)8-21-20(27)18-7-19(23-13-22-18)24-16-11-28-12-16/h1-4,7,13,16,20-21,27H,5-6,8-12H2,(H,22,23,24)
BRD-K45909031-001-01-5	SDGJBAUIGHSMRI-UHFFFAOYSA-N	WZ4003	72200024	AMPK inhibitor	trt	NA	CCC(=O)Nc1cccc(Oc2[nH]c(=Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1	InChI=1S/C25H29ClN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h5-9,14-16H,4,10-13H2,1-3H3,(H,28,33)(H,27,29,30)
BRD-K94455792-001-01-8	HQWTUOLCGKIECB-UHFFFAOYSA-N	ICG-001	124518205	beta-catenin inhibitor	trt	NA	O=C1C(Cc2ccc(O)cc2)N2C(=O)CCN(C(=O)NCc3ccccc3)C2CN1Cc1cccc2ccccc12	InChI=1S/C33H32N4O4/c38-27-15-13-23(14-16-27)19-29-32(40)35(21-26-11-6-10-25-9-4-5-12-28(25)26)22-30-36(18-17-31(39)37(29)30)33(41)34-20-24-7-2-1-3-8-24/h1-16,29-30,38H,17-22H2,(H,34,41)
BRD-K84937637-001-11-5	DVSZTYJRXBBIFA-UHFFFAOYSA-N	sirolimus	5284616	mTOR inhibitor	trt	NA	COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)=CC(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C	InChI=1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,33-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3
BRD-K44227013-001-08-0	PHXJVRSECIGDHY-UHFFFAOYSA-N	ponatinib	24826799	Bcr-Abl kinase inhibitor	trt	NA	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12	InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)
BRD-K13094524-001-04-2	TXZPMHLMPKIUGK-UHFFFAOYSA-N	PFI-1	71271629	bromodomain inhibitor	trt	NA	COc1ccccc1S(=O)(=O)Nc1ccc2c(c1)CN(C)C(=O)N2	InChI=1S/C16H17N3O4S/c1-19-10-11-9-12(7-8-13(11)17-16(19)20)18-24(21,22)15-6-4-3-5-14(15)23-2/h3-9,18H,10H2,1-2H3,(H,17,20)
BRD-K36234266-001-09-8	DLGOEMSEDOSKAD-UHFFFAOYSA-N	carmustine	2578	DNA inhibitor	trt	NA	O=C(NCCCl)N(CCCl)[N+][O-]	InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11)
BRD-K61688984-001-02-9	BLVQHYHDYFTPDV-UHFFFAOYSA-N	RGFP966	56650312	HDAC inhibitor	trt	NA	Nc1cc(F)ccc1NC(=O)C=Cc1cnn(CC=Cc2ccccc2)c1	InChI=1S/C21H19FN4O/c22-18-9-10-20(19(23)13-18)25-21(27)11-8-17-14-24-26(15-17)12-4-7-16-5-2-1-3-6-16/h1-11,13-15H,12,23H2,(H,25,27)
BRD-K33818169-003-04-6	NAXSRXHZFIBFMI-UHFFFAOYSA-N	GW-3965	447905	LXR agonist	trt	NA	O=C(O)Cc1cccc(OCCCN(Cc2cccc(C(F)(F)F)c2Cl)CC(c2ccccc2)c2ccccc2)c1	InChI=1S/C33H31ClF3NO3/c34-32-27(15-8-17-30(32)33(35,36)37)22-38(18-9-19-41-28-16-7-10-24(20-28)21-31(39)40)23-29(25-11-3-1-4-12-25)26-13-5-2-6-14-26/h1-8,10-17,20,29H,9,18-19,21-23H2,(H,39,40)
BRD-K60130390-001-02-1	RNAMYOYQYRYFQY-UHFFFAOYSA-N	UNC0642	53315878	histone lysine methyltransferase inhibitor	trt	NA	COc1cc2c(=NC3CCN(C(C)C)CC3)[nH]c(N3CCC(F)(F)CC3)nc2cc1OCCCN1CCCC1	InChI=1S/C29H44F2N6O2/c1-21(2)36-14-7-22(8-15-36)32-27-23-19-25(38-3)26(39-18-6-13-35-11-4-5-12-35)20-24(23)33-28(34-27)37-16-9-29(30,31)10-17-37/h19-22H,4-18H2,1-3H3,(H,32,33,34)
BRD-K72898849-001-01-8	TXEBNKKOLVBTFK-UHFFFAOYSA-N	BLU9931	72710839	FGFR inhibitor	trt	NA	C=CC(=O)Nc1cccc(C)c1N=c1nc2ccc(-c3c(Cl)c(OC)cc(OC)c3Cl)cc2c[nH]1	InChI=1S/C26H22Cl2N4O3/c1-5-21(33)30-18-8-6-7-14(2)25(18)32-26-29-13-16-11-15(9-10-17(16)31-26)22-23(27)19(34-3)12-20(35-4)24(22)28/h5-13H,1H2,2-4H3,(H,30,33)(H,29,31,32)
BRD-K32730239-001-01-0	NQQBNZBOOHHVQP-UHFFFAOYSA-N	SU3327	11837140	JNK inhibitor	trt	NA	N=c1[nH]nc(Sc2ncc([N+](=O)[O-])s2)s1	InChI=1S/C5H3N5O2S3/c6-3-8-9-5(14-3)15-4-7-1-2(13-4)10(11)12/h1H,(H2,6,8)
BRD-K19871656-001-01-3	GCWIQUVXWZWCLE-UHFFFAOYSA-N	CPI-0610	57389999	bromodomain inhibitor	trt	NA	Cc1noc2c1-c1ccccc1C(c1ccc(Cl)cc1)=NC2CC(N)=O	InChI=1S/C20H16ClN3O2/c1-11-18-14-4-2-3-5-15(14)19(12-6-8-13(21)9-7-12)23-16(10-17(22)25)20(18)26-24-11/h2-9,16H,10H2,1H3,(H2,22,25)
BRD-K67772619-001-05-1	FFWOKTFYGVYKIR-UHFFFAOYSA-N	rheochrysidin	10639	protein tyrosine kinase inhibitor	trt	NA	COc1cc(O)c2c(c1)C(=O)c1cc(C)cc(O)c1C2=O	InChI=1S/C16H12O5/c1-7-3-9-13(11(17)4-7)16(20)14-10(15(9)19)5-8(21-2)6-12(14)18/h3-6,17-18H,1-2H3
BRD-K56301217-001-07-4	HPLNQCPCUACXLM-UHFFFAOYSA-N	ABT-737	11228183	BCL inhibitor	trt	NA	CN(C)CCC(CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]	InChI=1S/C42H45ClN6O5S2/c1-46(2)23-22-35(30-55-37-9-4-3-5-10-37)44-40-21-20-38(28-41(40)49(51)52)56(53,54)45-42(50)32-14-18-36(19-15-32)48-26-24-47(25-27-48)29-33-8-6-7-11-39(33)31-12-16-34(43)17-13-31/h3-21,28,35,44H,22-27,29-30H2,1-2H3,(H,45,50)
BRD-K83192048-050-03-5	MVMQESMQSYOVGV-UHFFFAOYSA-N	dimethindene-(S)-(+)	6604866	acetylcholine receptor antagonist	trt	NA	CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1	InChI=1S/C20H24N2/c1-15(19-10-6-7-12-21-19)20-17(11-13-22(2)3)14-16-8-4-5-9-18(16)20/h4-10,12,15H,11,13-14H2,1-3H3
BRD-K57080016-001-01-9	CYOHGALHFOKKQC-UHFFFAOYSA-N	selumetinib	10127622	MEK inhibitor	trt	NA	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21	InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)
BRD-K73397362-001-06-6	FYBHCRQFSFYWPY-UHFFFAOYSA-N	purmorphamine	5284329	smoothened receptor agonist	trt	NA	c1ccc2c(Oc3nc(=Nc4ccc(N5CCOCC5)cc4)c4ncn(C5CCCCC5)c4[nH]3)cccc2c1	InChI=1S/C31H32N6O2/c1-2-9-25(10-3-1)37-21-32-28-29(33-23-13-15-24(16-14-23)36-17-19-38-20-18-36)34-31(35-30(28)37)39-27-12-6-8-22-7-4-5-11-26(22)27/h4-8,11-16,21,25H,1-3,9-10,17-20H2,(H,33,34,35)
BRD-K21728777-001-02-3	IVUGFMLRJOCGAS-UHFFFAOYSA-N	AMG900	24856041	Aurora kinase inhibitor	trt	NA	Cc1csc(-c2n[nH]c(=Nc3ccc(Oc4ncccc4-c4cc[nH]c(=N)n4)cc3)c3ccccc23)c1	InChI=1S/C28H21N7OS/c1-17-15-24(37-16-17)25-20-5-2-3-6-21(20)26(35-34-25)32-18-8-10-19(11-9-18)36-27-22(7-4-13-30-27)23-12-14-31-28(29)33-23/h2-16H,1H3,(H,32,35)(H2,29,31,33)
BRD-K83607951-001-02-2	HXMGCTFLLWPVFM-UHFFFAOYSA-N	skepinone-l	45279963	p38 MAPK inhibitor	trt	NA	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCC(O)CO)cc21	InChI=1S/C24H21F2NO4/c25-16-4-8-23(22(26)10-16)27-17-5-7-20-15(9-17)2-1-14-3-6-19(11-21(14)24(20)30)31-13-18(29)12-28/h3-11,18,27-29H,1-2,12-13H2
BRD-K70642949-001-04-5	QLPHOXTXAKOFMU-UHFFFAOYSA-N	GSK2334470	46215815	phosphoinositide dependent kinase inhibitor	trt	NA	CN=c1nc(-c2ccc3c(=N)[nH][nH]c3c2)cc(N2CC(C(=O)NC3CCCCC3)CCC2C)[nH]1	InChI=1S/C25H34N8O/c1-15-8-9-17(24(34)28-18-6-4-3-5-7-18)14-33(15)22-13-20(29-25(27-2)30-22)16-10-11-19-21(12-16)31-32-23(19)26/h10-13,15,17-18H,3-9,14H2,1-2H3,(H,28,34)(H3,26,31,32)(H,27,29,30)
BRD-K28132190-001-02-0	OINGHOPGNMYCAB-UHFFFAOYSA-N	NVS-PAK1-1	122187564	p21 activated kinase inhibitor	trt	NA	CC(C)NC(=O)N1CCC(N=C2Nc3cc(F)ccc3N(CC(F)F)c3ccc(Cl)cc32)C1	InChI=1S/C23H25ClF3N5O/c1-13(2)28-23(33)31-8-7-16(11-31)29-22-17-9-14(24)3-5-19(17)32(12-21(26)27)20-6-4-15(25)10-18(20)30-22/h3-6,9-10,13,16,21H,7-8,11-12H2,1-2H3,(H,28,33)(H,29,30)
BRD-K66401437-001-03-3	NJSVYIXLKIJTAN-UHFFFAOYSA-N	THZ1	73602827	CDK inhibitor	trt	NA	CN(C)C=CCC(=O)Nc1ccc(C(=O)Nc2cccc(N=c3nc(-c4c[nH]c5ccccc45)c(Cl)c[nH]3)c2)cc1	InChI=1S/C31H28ClN7O2/c1-39(2)16-6-11-28(40)35-21-14-12-20(13-15-21)30(41)36-22-7-5-8-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-10-4-3-9-24(25)27/h3-10,12-19,33H,11H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38)
BRD-K82164249-001-03-5	YVXVTLGIDOACBJ-UHFFFAOYSA-N	andarine	9824562	androgen receptor modulator	trt	NA	CC(=O)Nc1ccc(OCC(C)(O)C(=O)Nc2ccc([N+](=O)[O-])c(C(F)(F)F)c2)cc1	InChI=1S/C19H18F3N3O6/c1-11(26)23-12-3-6-14(7-4-12)31-10-18(2,28)17(27)24-13-5-8-16(25(29)30)15(9-13)19(20,21)22/h3-9,28H,10H2,1-2H3,(H,23,26)(H,24,27)
BRD-K72951360-001-01-4	TWNRWNXYVFLAMA-UHFFFAOYSA-N	valrubicin	454216	DNA inhibitor	trt	NA	CCCCC(=O)OCC(=O)C1(O)C=C(OC2CC(NC(=O)C(F)(F)F)C(O)C(C)O2)c2c(c(O)c3c(O)c4cccc(OC)c4c(O)c3c2O)C1	InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,12,14,17,22,27,41-45,47H,4-5,9-11,13H2,1-3H3,(H,38,46)
BRD-K56932272-001-02-9	XEVJUIZOZCFECP-UHFFFAOYSA-N	BMS-566419	9913339	inosine monophosphate dehydrogenase inhibitor	trt	NA	CCN1CCN(c2ccc(C(C)(C)NC(=O)c3cc4[nH]c5ccccc5c(=O)c4cc3F)cn2)CC1	InChI=1S/C28H30FN5O2/c1-4-33-11-13-34(14-12-33)25-10-9-18(17-30-25)28(2,3)32-27(36)20-16-24-21(15-22(20)29)26(35)19-7-5-6-8-23(19)31-24/h5-10,15-17H,4,11-14H2,1-3H3,(H,31,35)(H,32,36)
BRD-K03063480-001-06-6	BPUJSTYCIQYLIZ-UHFFFAOYSA-N	PF-477736	NA	CHK inhibitor	trt	NA	Cn1cc(-c2nc3cc(=NC(O)C(N)C4CCCCC4)cc4c(=O)[nH]ncc2c34)cn1	InChI=1S/C22H25N7O2/c1-29-11-13(9-25-29)20-16-10-24-28-21(30)15-7-14(8-17(27-20)18(15)16)26-22(31)19(23)12-5-3-2-4-6-12/h7-12,19,22,31H,2-6,23H2,1H3,(H,28,30)
BRD-K88677950-001-03-9	UHAXDAKQGVISBZ-UHFFFAOYSA-N	PD-198306	9956637	MAP kinase inhibitor	trt	NA	Cc1cc(I)ccc1Nc1c(C(=O)NOCC2CC2)cc(F)c(F)c1F	InChI=1S/C18H16F3IN2O2/c1-9-6-11(22)4-5-14(9)23-17-12(7-13(19)15(20)16(17)21)18(25)24-26-8-10-2-3-10/h4-7,10,23H,2-3,8H2,1H3,(H,24,25)
BRD-K50055394-001-03-6	NBHPRWLFLUBAIE-UHFFFAOYSA-N	halopemide	65490	phospholipase inhibitor	trt	NA	O=C(NCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1ccc(F)cc1	InChI=1S/C21H22ClFN4O2/c22-15-3-6-19-18(13-15)25-21(29)27(19)17-7-10-26(11-8-17)12-9-24-20(28)14-1-4-16(23)5-2-14/h1-6,13,17H,7-12H2,(H,24,28)(H,25,29)
BRD-A78210457-001-01-5	QBGKPEROWUKSBK-UHFFFAOYSA-N	RG7112	76525291	MDM inhibitor	trt	NA	CCOc1cc(C(C)(C)C)ccc1C1=NC(C)(c2ccc(Cl)cc2)C(C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1	InChI=1S/C38H48Cl2N4O4S/c1-8-48-33-26-29(36(2,3)4)14-19-32(33)34-41-37(5,27-10-15-30(39)16-11-27)38(6,28-12-17-31(40)18-13-28)44(34)35(45)43-23-21-42(22-24-43)20-9-25-49(7,46)47/h10-19,26H,8-9,20-25H2,1-7H3
BRD-K76908866-001-07-6	LLVZBTWPGQVVLW-UHFFFAOYSA-N	CP-724714	9874913	EGFR inhibitor	trt	NA	COCC(=O)NCC=Cc1ccc2[nH]cnc(=Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1	InChI=1S/C27H27N5O3/c1-18-13-21(8-11-25(18)35-22-9-6-19(2)29-15-22)32-27-23-14-20(7-10-24(23)30-17-31-27)5-4-12-28-26(33)16-34-3/h4-11,13-15,17H,12,16H2,1-3H3,(H,28,33)(H,30,31,32)
BRD-K06883221-001-01-9	MAVDNGWEBZTACC-UHFFFAOYSA-N	apratastat	11452716	tumor necrosis factor production inhibitor	trt	NA	CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CCO)cc2)C1C(O)=NO	InChI=1S/C17H22N2O6S2/c1-17(2)15(16(21)18-22)19(9-12-26-17)27(23,24)14-7-5-13(6-8-14)25-11-4-3-10-20/h5-8,15,20,22H,9-12H2,1-2H3,(H,18,21)
BRD-M87138257-003-01-1	XSIOKTWDEOJMGG-UHFFFAOYSA-O	acriflavine	452192	hypoxia inducible factor inhibitor	trt	NA	C[n+]1c2cc(N)ccc2cc2ccc(N)cc21	InChI=1S/C14H13N3/c1-17-13-7-11(15)4-2-9(13)6-10-3-5-12(16)8-14(10)17/h2-8H,1H3,(H3,15,16)/p+1
BRD-K75009076-001-02-1	KUFDZBFFAKTDQE-UHFFFAOYSA-N	SCH-900776	46239015	CHK inhibitor	trt	NA	Cn1cc(-c2c[nH]n3c(=N)c(Br)c(C4CCCNC4)nc23)cn1	InChI=1S/C15H18BrN7/c1-22-8-10(6-19-22)11-7-20-23-14(17)12(16)13(21-15(11)23)9-3-2-4-18-5-9/h6-9,17-18,20H,2-5H2,1H3
BRD-K49669041-001-08-4	DMMILYKXNCVKOJ-UHFFFAOYSA-N	BX-912	11754511	pyruvate dehydrogenase kinase inhibitor	trt	NA	O=C(Nc1cccc(N=c2[nH]cc(Br)c(=NCCc3c[nH]cn3)[nH]2)c1)N1CCCC1	InChI=1S/C20H23BrN8O/c21-17-12-24-19(28-18(17)23-7-6-16-11-22-13-25-16)26-14-4-3-5-15(10-14)27-20(30)29-8-1-2-9-29/h3-5,10-13H,1-2,6-9H2,(H,22,25)(H,27,30)(H2,23,24,26,28)
BRD-K20290250-001-02-1	WGPXKFOFEXJMBD-UHFFFAOYSA-N	BIX-02188	66524294	MEK inhibitor	trt	NA	CN(C)Cc1cccc(N=C(c2ccccc2)c2c(O)[nH]c3cc(C(N)=O)ccc23)c1	InChI=1S/C25H24N4O2/c1-29(2)15-16-7-6-10-19(13-16)27-23(17-8-4-3-5-9-17)22-20-12-11-18(24(26)30)14-21(20)28-25(22)31/h3-14,28,31H,15H2,1-2H3,(H2,26,30)
BRD-K06182768-001-06-4	BKCDJTRMYWSXMC-UHFFFAOYSA-N	A-366	76285486	histone lysine methyltransferase inhibitor	trt	NA	COc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCC1	InChI=1S/C19H27N3O2/c1-23-16-12-14-15(21-18(20)19(14)6-4-7-19)13-17(16)24-11-5-10-22-8-2-3-9-22/h12-13H,2-11H2,1H3,(H2,20,21)
BRD-K73982490-001-02-9	QFRLDZGQEZCCJZ-UHFFFAOYSA-N	BI-78D3	2747117	JNK inhibitor	trt	NA	O=c1[nH]nc(Sc2ncc([N+](=O)[O-])s2)n1-c1ccc2c(c1)OCCO2	InChI=1S/C13H9N5O5S2/c19-11-15-16-12(25-13-14-6-10(24-13)18(20)21)17(11)7-1-2-8-9(5-7)23-4-3-22-8/h1-2,5-6H,3-4H2,(H,15,19)
BRD-K91900765-001-08-4	VEPKQEUBKLEPRA-UHFFFAOYSA-N	VX-745	3038525	p38 MAPK inhibitor	trt	NA	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl	InChI=1S/C19H9Cl2F2N3OS/c20-11-2-1-3-12(21)17(11)18-14-5-7-16(25-26(14)9-24-19(18)27)28-15-6-4-10(22)8-13(15)23/h1-9H
BRD-K24600306-003-02-9	XAPVAKKLQGLNOY-UHFFFAOYSA-N	ML-298	53393916	phospholipase inhibitor	trt	NA	O=C(NCCN1CCC2(CC1)C(=O)NCN2c1cccc(F)c1)c1ccc(F)c(F)c1	InChI=1S/C22H23F3N4O2/c23-16-2-1-3-17(13-16)29-14-27-21(31)22(29)6-9-28(10-7-22)11-8-26-20(30)15-4-5-18(24)19(25)12-15/h1-5,12-13H,6-11,14H2,(H,26,30)(H,27,31)
BRD-K53665955-001-03-0	LCVIRAZGMYMNNT-UHFFFAOYSA-N	MK-5108	NA	Aurora kinase inhibitor	trt	NA	O=C(O)C1(Cc2cccc(=Nc3nccs3)[nH]2)CCC(Oc2cccc(Cl)c2F)CC1	InChI=1S/C22H21ClFN3O3S/c23-16-4-2-5-17(19(16)24)30-15-7-9-22(10-8-15,20(28)29)13-14-3-1-6-18(26-14)27-21-25-11-12-31-21/h1-6,11-12,15H,7-10,13H2,(H,28,29)(H,25,26,27)
BRD-K87632963-001-05-9	IIQUYGWWHIHOCF-UHFFFAOYSA-N	GNF-5	44129660	Bcr-Abl kinase inhibitor	trt	NA	O=C(NCCO)c1cccc(-c2cc(=Nc3ccc(OC(F)(F)F)cc3)[nH]cn2)c1	InChI=1S/C20H17F3N4O3/c21-20(22,23)30-16-6-4-15(5-7-16)27-18-11-17(25-12-26-18)13-2-1-3-14(10-13)19(29)24-8-9-28/h1-7,10-12,28H,8-9H2,(H,24,29)(H,25,26,27)
BRD-A87435144-001-01-6	DTDZLJHKVNTQGZ-UHFFFAOYSA-N	AZD7545	9805105	pyruvate dehydrogenase kinase inhibitor	trt	NA	CN(C)C(=O)c1ccc(S(=O)(=O)c2ccc(NC(=O)C(C)(O)C(F)(F)F)c(Cl)c2)cc1	InChI=1S/C19H18ClF3N2O5S/c1-18(28,19(21,22)23)17(27)24-15-9-8-13(10-14(15)20)31(29,30)12-6-4-11(5-7-12)16(26)25(2)3/h4-10,28H,1-3H3,(H,24,27)
BRD-K85606544-001-09-1	JWNPDZNEKVCWMY-UHFFFAOYSA-N	neratinib	9915743	EGFR inhibitor	trt	NA	CCOc1cc2[nH]cc(C#N)c(=Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)C=CCN(C)C	InChI=1S/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)
BRD-K01826510-300-06-9	ZQDWXGKKHFNSQK-UHFFFAOYSA-N	hydroxyzine	3658	antihistamine	trt	NA	OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	InChI=1S/C21H27ClN2O2/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-9,21,25H,10-17H2
BRD-K68756823-001-07-1	XVECMUKVOMUNLE-UHFFFAOYSA-N	FR-180204	11493598	MAP kinase inhibitor	trt	NA	N=c1[nH][nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12	InChI=1S/C18H13N7/c19-17-12-10-13(20-22-18(12)23-21-17)15-14-8-4-5-9-25(14)24-16(15)11-6-2-1-3-7-11/h1-10H,(H3,19,21,22,23)
BRD-K23383398-001-09-9	SGIWFELWJPNFDH-UHFFFAOYSA-N	T-0901317	447912	LXR agonist	trt	NA	O=S(=O)(c1ccccc1)N(CC(F)(F)F)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1	InChI=1S/C17H12F9NO3S/c18-14(19,20)10-27(31(29,30)13-4-2-1-3-5-13)12-8-6-11(7-9-12)15(28,16(21,22)23)17(24,25)26/h1-9,28H,10H2
BRD-K86718786-001-03-9	DMIDPTCQPIJYFE-UHFFFAOYSA-N	SGC-707	90642938	protein arginine N-methyltransferase inhibitor	trt	NA	O=C(NCC(=O)N1CCCC1)Nc1ccc2cnccc2c1	InChI=1S/C16H18N4O2/c21-15(20-7-1-2-8-20)11-18-16(22)19-14-4-3-13-10-17-6-5-12(13)9-14/h3-6,9-10H,1-2,7-8,11H2,(H2,18,19,22)
BRD-K09372874-001-01-0	JBPUGFODGPKTDW-UHFFFAOYSA-N	merimepodib	153241	inosine monophosphate dehydrogenase inhibitor	trt	NA	COc1cc(NC(=O)Nc2cccc(CNC(=O)OC3CCOC3)c2)ccc1-c1cnco1	InChI=1S/C23H24N4O6/c1-30-20-10-17(5-6-19(20)21-12-24-14-32-21)27-22(28)26-16-4-2-3-15(9-16)11-25-23(29)33-18-7-8-31-13-18/h2-6,9-10,12,14,18H,7-8,11,13H2,1H3,(H,25,29)(H2,26,27,28)
BRD-K54759182-003-08-0	PHTUQLWOUWZIMZ-UHFFFAOYSA-N	dosulepin	5284550	tricyclic antidepressant	trt	NA	CN(C)CCC=C1c2ccccc2CSc2ccccc21	InChI=1S/C19H21NS/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3
BRD-K99092662-001-01-1	ZHVQJONIPYDBTP-UHFFFAOYSA-N	PS178990	9882972	androgen receptor modulator	trt	NA	Cc1c(-n2c(O)c3n(c2=O)CCC3O)ccc(C#N)c1Cl	InChI=1S/C14H12ClN3O3/c1-7-9(3-2-8(6-16)11(7)15)18-13(20)12-10(19)4-5-17(12)14(18)21/h2-3,10,19-20H,4-5H2,1H3
BRD-K99113996-001-02-0	JUSFANSTBFGBAF-UHFFFAOYSA-N	AZD2014	25262792	mTOR inhibitor	trt	NA	CNC(=O)c1cccc(-c2ccc3c(N4CCOCC4C)nc(N4CCOCC4C)nc3n2)c1	InChI=1S/C25H30N6O3/c1-16-14-33-11-9-30(16)23-20-7-8-21(18-5-4-6-19(13-18)24(32)26-3)27-22(20)28-25(29-23)31-10-12-34-15-17(31)2/h4-8,13,16-17H,9-12,14-15H2,1-3H3,(H,26,32)
BRD-A22769835-300-05-7	WEUCDJCFJHYFRL-UHFFFAOYSA-N	homochlorcyclizine	3627	antihistamine	trt	NA	CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1	InChI=1S/C19H23ClN2/c1-21-12-5-13-22(15-14-21)19(16-6-3-2-4-7-16)17-8-10-18(20)11-9-17/h2-4,6-11,19H,5,12-15H2,1H3
BRD-K39520573-001-03-8	LMXYVLFTZRPNRV-UHFFFAOYSA-N	GW-5074	5034	RAF inhibitor	trt	NA	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1	InChI=1S/C15H8Br2INO2/c16-11-4-7(5-12(17)14(11)20)3-10-9-6-8(18)1-2-13(9)19-15(10)21/h1-6,20H,(H,19,21)
BRD-A53576514-048-14-3	QVYRGXJJSLMXQH-UHFFFAOYSA-N	orphenadrine	4601	acetylcholine receptor antagonist	trt	NA	Cc1ccccc1C(OCCN(C)C)c1ccccc1	InChI=1S/C18H23NO/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16/h4-12,18H,13-14H2,1-3H3
BRD-K61397605-001-07-5	SOOPLNPQGWJZHY-UHFFFAOYSA-N	romidepsin	5352062	HDAC inhibitor	trt	NA	CCC1=NC(=O)C2CSSCCC=CC(CC(=O)NC(C(C)C)C(=O)N2)OC(=O)C(C(C)C)NC1=O	InChI=1S/C24H36N4O6S2/c1-6-16-21(30)28-20(14(4)5)24(33)34-15-9-7-8-10-35-36-12-17(22(31)25-16)26-23(32)19(13(2)3)27-18(29)11-15/h7,9,13-15,17,19-20H,6,8,10-12H2,1-5H3,(H,26,32)(H,27,29)(H,28,30)
BRD-K12511835-003-01-2	JJWLXRKVUJDJKG-UHFFFAOYSA-N	BMS-863233	57899889	CDC inhibitor	trt	NA	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12	InChI=1S/C14H12ClN3O2/c15-7-3-4-10-8(6-7)11-12(20-10)14(19)18-13(17-11)9-2-1-5-16-9/h3-4,6,9,16H,1-2,5H2,(H,17,18,19)
BRD-K30707190-001-04-1	JJEDWBQZCRESJL-UHFFFAOYSA-N	PNU-74654	9836739	beta-catenin inhibitor	trt	NA	Cc1ccc(C=NNC(=O)c2ccccc2Oc2ccccc2)o1	InChI=1S/C19H16N2O3/c1-14-11-12-16(23-14)13-20-21-19(22)17-9-5-6-10-18(17)24-15-7-3-2-4-8-15/h2-13H,1H3,(H,21,22)
BRD-K53972329-001-07-0	HFNKQEVNSGCOJV-UHFFFAOYSA-N	ruxolitinib	25126798	JAK inhibitor	trt	NA	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1	InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)
BRD-K24696047-001-02-3	AECDBHGVIIRMOI-UHFFFAOYSA-N	NVP-AEW541	NA	IGF-1 inhibitor	trt	NA	N=c1[nH]cnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCC2)C1	InChI=1S/C27H29N5O/c28-26-25-24(21-8-4-9-23(14-21)33-17-19-6-2-1-3-7-19)16-32(27(25)30-18-29-26)22-12-20(13-22)15-31-10-5-11-31/h1-4,6-9,14,16,18,20,22H,5,10-13,15,17H2,(H2,28,29,30)
BRD-K98251413-001-04-0	CAOSCCRYLYQBES-UHFFFAOYSA-N	IOX2	54685215	hypoxia inducible factor inhibitor	trt	NA	O=C(O)CNC(=O)c1c(O)c2ccccc2n(Cc2ccccc2)c1=O	InChI=1S/C19H16N2O5/c22-15(23)10-20-18(25)16-17(24)13-8-4-5-9-14(13)21(19(16)26)11-12-6-2-1-3-7-12/h1-9,24H,10-11H2,(H,20,25)(H,22,23)
BRD-A12994259-001-02-1	UVSMNLNDYGZFPF-UHFFFAOYSA-N	pomalidomide	134780	tumor necrosis factor production inhibitor	trt	NA	Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O	InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18)
BRD-K02965346-001-07-5	YTYGVVYTPPUYRI-UHFFFAOYSA-N	SU-11274	9549297	hepatocyte growth factor receptor inhibitor	trt	NA	C=c1[nH]c(=Cc2c(O)[nH]c3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc23)c(C)c1C(=O)N1CCN(C)CC1	InChI=1S/C28H30ClN5O4S/c1-17-25(30-18(2)26(17)28(36)34-12-10-32(3)11-13-34)16-23-22-15-21(8-9-24(22)31-27(23)35)39(37,38)33(4)20-7-5-6-19(29)14-20/h5-9,14-16,30-31,35H,2,10-13H2,1,3-4H3
BRD-K04923131-001-15-4	SAQUSDSPQYQNBG-UHFFFAOYSA-N	GSK-3-inhibitor-IX	NA	glycogen synthase kinase inhibitor	trt	NA	O=Nc1c(-c2c(O)[nH]c3cc(Br)ccc23)[nH]c2ccccc12	InChI=1S/C16H10BrN3O2/c17-8-5-6-9-12(7-8)19-16(21)13(9)15-14(20-22)10-3-1-2-4-11(10)18-15/h1-7,18-19,21H
BRD-K16189898-003-03-3	AQGNHMOJWBZFQQ-UHFFFAOYSA-N	CHIR-99021	9956119	glycogen synthase kinase inhibitor	trt	NA	Cc1c[nH]c(-c2c[nH]c(=NCCN=c3ccc(C#N)c[nH]3)nc2-c2ccc(Cl)cc2Cl)n1	InChI=1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32)
BRD-K13606314-001-01-3	LKZLGMAAKNEGCH-UHFFFAOYSA-N	P5091	2819993	ubiquitin specific protease inhibitor	trt	NA	CC(=O)c1cc([N+](=O)[O-])c(Sc2cccc(Cl)c2Cl)s1	InChI=1S/C12H7Cl2NO3S2/c1-6(16)10-5-8(15(17)18)12(20-10)19-9-4-2-3-7(13)11(9)14/h2-5H,1H3
NA	IAZDPXIOMUYVGZ-UHFFFAOYSA-N	DMSO	679	NA	control	negcon	C[S+](C)[O-]	InChI=1S/C2H6OS/c1-4(2)3/h1-2H3
Compound2	NA	Compound2	NA	kinesin inhibitor	trt	NA	NA	NA
Compound8	NA	Compound8	NA	phosphodiesterase inhibitor	trt	NA	NA	NA
Compound1	NA	Compound1	NA	HMGCR inhibitor	trt	NA	NA	NA
Compound7	NA	Compound7	NA	FGFR inhibitor	trt	NA	NA	NA
Compound5	NA	Compound5	NA	IGF-1 inhibitor	trt	NA	NA	NA
Compound4	NA	Compound4	NA	PARP inhibitor	trt	NA	NA	NA
Compound3	NA	Compound3	NA	BCL inhibitor	trt	NA	NA	NA
Compound6	NA	Compound6	NA	tricyclic antidepressant	trt	NA	NA	NA
